HT-2022-000043, HT-2022-000363 - [2024] EWHC 1708 (TCC)
Technology and Construction Court

HT-2022-000043, HT-2022-000363 - [2024] EWHC 1708 (TCC)

Fecha: 03-Jul-2024

The submissions

The submissions

11.

Mr Bowsher KC relied upon a range of indications that Santé is to be treated, on the balance of the evidence, as having practical control over the documents held by Bio and Boson which are responsive to the categories of disclosure which have been ordered in this case. I summarise the more important of these as follows.

12.

First, undertakings have been made whereby Bio and Boson have committed to providing Santé with assistance in terms which are applicable to the claim. Clause 6.14(a) of the contract between Santé and Bio states:

“The Supplier shall, at Santé’s request, promptly provide (and procure that the Manufacturer provides) Santé with all reasonable assistance requested by Santé in connection with:

(a)

any dispute between [Santé] and the [SoS] in relation to a claim that Goods supplied to the [SoS] are defective or not in accordance with the Client Contract…”

In this clause, Bio is “the Supplier” and Boson is “the Manufacturer”.

13.

There is a similar clause in a letter written by Boson to Bio which has been described by the Claimants as the contract between Bio and Boson. §13 of that document contains an undertaking, given expressly both for Bio’s benefit and for Santé’s benefit:

“To assist you and [Santé] on request in connection with either (i) any dispute which may arise between [Santé] and [the SoS] in relation to a claim that Goods supplied to [the SoS] are defective or not in accordance with the Client Contract…”.

14.

The Claimants do not deny that these clauses (“contractual assistance clauses”) are apt to cover the current dispute between them and the Defendant, which concerns whether the production of “the Goods” is or was in accordance with the contract between them and the Defendant. Whilst the clauses do not refer in terms to documents, Ms Hannaford did not dispute that the wording of the clauses is sufficiently broad as to cover the provision of documents which are necessary for the resolution of a dispute regarding whether or not “the Goods” are in accordance with the contract. Whilst Mr Bowsher does not rely upon these clauses as establishing an enforceable legal right of access to the documents in question, not least because the Defendant remains unsure as to whether it has received all of the relevant contractual documents, he does rely upon them as providing a firm foundation for the de facto control for which he argues.

15.

Second, Mr Bowsher submits that, both prior to and for the purposes of these proceedings, there has in fact already been extensive provision of documentation to Santé from Bio and/or Boson, consistent with the effect of the contractual assistance clauses. In particular:

(1)

A number of the documents provided by the Claimants by way of initial disclosure in the proceedings can only have originated from Boson.

(2)

The Claimants received documents from Boson, for provision to the Defendant, in late October 2021 and again in November 2021, in the immediate aftermath of the QIMA Audit report.

(3)

In October 2023, the Claimants requested from Bio a copy of the purchase order which it had issued as part of its contract with Boson. This was not provided immediately but was provided in early June 2024 after a similar request had been made to Bio’s solicitors (along with a quality agreement between Bio and Boson).

The Defendant complains, with some justification, that the Claimants have been deliberately vague about the nature and circumstances of the requests for documents that they have made to Boson and Bio, refusing to disclose them or even elucidate upon them until the very eve of the hearing. Certain of the requests, it turns out, were made orally or - in one case – may have been made orally (the relevant individual not being sure about whether he made the request – as recently as October 2023 - orally or in writing).

16.

Third, Boson has provided and will continue to provide other forms of assistance to the Claimants in prosecuting their claim, including by making available employees to give evidence on behalf of the Claimants at trial. Indeed, Mr Bowsher asks me to infer that Boson has a strong interest and perhaps even a direct financial interest in the Claimants’ success. There is no direct evidence of the latter, although I can accept that it would likely be in Boson’s commercial interests to “clear its name” of the allegations made by the Defendant and of the fact of the Claimants’ contract with the Defendant having been terminated for breach of contract on account of Boson’s conduct (something which may have to be disclosed, and may prejudice Boson, in other tender processes). It is also undoubtedly correct that prior to and upon commencement of the claim, the Claimants and Boson were presenting a united front in opposition to the Defendant’s allegations, and that a number of averments made by the Claimants in their Statements of Case must have been based upon information provided to them by Boson.

17.

Fourth, although the Claimants claim that there was no contractual relationship between Santé and Boson, Mr Bowsher pointed to a number of indications that Santé has been in direct contact with Boson and enjoyed significant power in that relationship. For example, in July 2021, and before the Defendant awarded the contract to the Claimants, Santé commissioned an audit of Boson’s premises by a firm called Intertek. A further audit was commissioned by Santé, by a firm called V-Trust, after the QIMA audit. The Claimants do not dispute that the Intertek and V-Trust auditors were given access to Boson’s documents for the purposes of conducting their audits. As already noted, Boson gave undertakings for the benefit of Santé as well as Bio and these included a right for an employee of Santé (not Bio) to be located on Boson’s premises to monitor production of the test kits and compliance by Boson with its various obligations.

18.

Fifth, Mr Bowsher emphasised the unfairness of the position if the Claimants were able to produce and rely upon documentation originating from Boson which was helpful to them, whilst not being subject to any obligations in relation to other documentation held by Boson which might undermine their case. Or, put another way, it would be unfair if the Claimants were able to rely upon the contractual assistance clauses to their advantage but without risking any disadvantage in terms of the documents provided by Boson. I should say that the Claimants had in fact offered to make requests to Boson which were formulated by the Defendant but this offer was not accepted, in part because the Claimants would not accept that they had any disclosure obligations in relation to Boson’s documents and in part also because of the difficulties which the Defendant perceived in making specific requests for documents without knowing enough about the universe of documents held by Boson.

19.

For her part, Ms Hannaford for the Claimants emphasised the following points:

(1)

There was nothing more than an ad hoc commercial relationship between Santé, Bio and Boson and the authorities show that it is necessary for there to be something more than even a close commercial relationship. None of the authorities concerned a relationship as distant as contractor-sub-contractor, most of the cases being concerned with parent company/subsidiary, employer/employee and trust/beneficiary relationships.

(2)

The contractual assistance clauses do not mention provision of documents and do not suggest the “free and unfettered right of access” which, she said, would be necessary to found a conclusion of de facto control. She asserted that clauses such as the contractual assistance clauses are common in contractor/sub-contractor relationships and did no more than reflect a similar assistance clause in the contract between the Claimants and the Defendant. If clauses like these were sufficient to give a contractor control of the documents of a subcontractor (or a sub-contractor control of the documents of a sub-sub-contractor) then there would be what she described as “an astonishing floodgates problem”.

(3)

All that had happened in this case was that Boson had responded to a limited number of requests for documents from Santé in reaction to a specific event. This was not suggestive of a standing arrangement of the type necessary to found de facto control.

(4)

There was nothing in the contractual assistance clauses to suggest that Boson’s documents would be available for searching by Santé, yet the effect of granting the declaration sought by the Defendant would be to require Santé to conduct a reasonable and proportionate search of Boson’s documents for documents responding to the relevant categories of the DRD, which it would be unable to do. She pointed out that in Pipia the Court had found there to be a continuing right to make requests for documents which constituted control and held that the appropriate course of action was to order Model C, request-based disclosure in relation to the relevant categories of documents.